Skip to main content
OpenTrials
Completed

NCT Number: NCT00965536

Nis Register Study Comparing Seroquel and Seroquel Prolong

The general aim of this non interventional study is to clarify what are the current clinical treatment practices of Quetiapine Immediate Release and Quetiapine Extended Release. The primary objectives of the study are:1.To collect information on the used Quetiapine Immediate Release or Quetiapine Extended Release medication 2.To collect information on duration and number of hospitalisation days 3.Change of GAF points

Completed

Looking for future studies?

Notify Me

Key information

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Medication: Seroquel or Seroquel Prolong
  • Diagnosis: F20-F29 or F30-F31 (ICD-10)
  • In-patient

Exclusion criteria

  • None

Treatment and study plan

Primary outcomes

  1. Hospitalisation time

    Time frame: 2008-2010

  2. Treatment practice

    Time frame: 2008-2010

Secondary outcomes

  1. Primary diagnosis

    Time frame: 2008-2010

  2. Medication at the end of hospitalisation

    Time frame: 2008-2010

  3. GAF rating points

    Time frame: 2008-2010

Sponsors and collaborators

Lead sponsor

AstraZeneca

Industry

Registry information

Official study title

A Local Non Interventional Retrospective Register Study of the Current Clinical Treatment Practices and the Number of Hospitalization Days With Seroquel or Seroquel Prolong.

Important dates

Study start
2009
Primary completion
2010
Study completion
2010
First posted
Aug 25, 2009
Registry last updated
Feb 16, 2011

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.